5-Bromo-6-chloropyridin-2-ol

Catalog No. :
ACTXMU062
CAS No. :
1227603-81-7
Molecular Formula :
C5H3BrClNO
Molecular Weight :
208.44

IUPAC Name:5-bromo-6-chloropyridin-2-ol

5-Bromo-6-chloropyridin-2-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg96%$137.00Login to see priceInquiryInquiry
1g96%$332.00Login to see priceInquiryInquiry
5g96%$957.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-6-chloropyridin-2-ol
IUPAC Name5-bromo-6-chloropyridin-2-ol
MDL No.MFCD16606309
Molecular FormulaC5H3BrClNO
Molecular Weight208.44
SMILESOC1=NC(Cl)=C(Br)C=C1
InChI KeyZBUYQOPMGPFMJU-UHFFFAOYSA-N
Synonym5-BROMO-6-CHLOROPYRIDIN-2-OL | 1227603-81-7 | 5-bromo-6-chloro-1H-pyridin-2-one | 5-Bromo-6-chloro-2-hydroxypyridine | MFCD16606309 | SCHEMBL11102043 | DTXSID90607668 | ZBUYQOPMGPFMJU-UHFFFAOYSA-N | 3-Bromo-2-chloro-6-hydroxypyridine | AC3279 | 5-Bromo-6-chloropyridin-2(1H)-
CAS No.1227603-81-7
PubChem CID20473287

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P233-P260-P261-P264-P270-P271-P280-P301+P312-P302+P352-P304-P304+P340-P305+P351+P338-P312-P321-P330-P332+P313-P337+P313-P340-P362-P403-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTXMU062 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXTZO521 route compound structure diagram
    ACXTZO521777931-67-6 In Stock
  2. Then
  3. ACTXMU062 route product structure diagram
    ACTXMU0621227603-81-7
Inquiry

2. ACTXMU062 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7 In Stock
  4. Then
  5. ACTXMU062 route product structure diagram
    ACTXMU0621227603-81-7
Inquiry

Comments (0)